Latest Insider Transactions at Aveanna Healthcare Holdings, Inc. (AVAH)
This section provides a real-time view of insider transactions for Aveanna Healthcare Holdings, Inc. (AVAH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aveanna Healthcare Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aveanna Healthcare Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2023
|
Victor F Ganzi |
BUY
Open market or private purchase
|
Direct |
3,200
+1.34%
|
$3,200
$1.18 P/Share
|
|
May 31
2023
|
Victor F Ganzi |
BUY
Open market or private purchase
|
Direct |
11,850
+4.84%
|
$11,850
$1.15 P/Share
|
|
May 30
2023
|
Victor F Ganzi |
BUY
Open market or private purchase
|
Direct |
1,758
+0.79%
|
$1,758
$1.14 P/Share
|
|
Feb 14
2023
|
Jeff Shaner Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
421,094
+20.34%
|
-
|
|
Feb 14
2023
|
Edwin C. Reisz Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
187,500
+14.79%
|
-
|
|
Feb 14
2023
|
Patrick A. Cunningham Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,594
+24.01%
|
-
|
|
Feb 14
2023
|
Beth Rubio Chief Nursing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,313
+26.02%
|
-
|
|
Feb 14
2023
|
David Afshar Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
314,688
+34.29%
|
-
|
|
Feb 14
2023
|
Shannon Drake Officer |
BUY
Grant, award, or other acquisition
|
Direct |
187,500
+31.97%
|
-
|
|
Feb 14
2023
|
Rodney D Windley |
BUY
Grant, award, or other acquisition
|
Direct |
119,048
+5.9%
|
-
|
|
Aug 24
2022
|
David Afshar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+3.35%
|
$20,000
$2.01 P/Share
|
|
Jun 30
2022
|
Richard C Zoretic |
BUY
Exercise of conversion of derivative security
|
Direct |
10,509
+25.31%
|
-
|
|
Jun 30
2022
|
Sheldon M Retchin |
BUY
Exercise of conversion of derivative security
|
Direct |
10,509
+11.91%
|
-
|
|
Jun 30
2022
|
Erica Schwartz |
BUY
Exercise of conversion of derivative security
|
Direct |
10,509
+50.0%
|
-
|
|
Jun 30
2022
|
Victor F Ganzi |
BUY
Exercise of conversion of derivative security
|
Direct |
10,509
+4.57%
|
-
|
|
Jun 30
2022
|
Steven E Rodgers |
BUY
Exercise of conversion of derivative security
|
Direct |
10,509
+18.43%
|
-
|
|
May 26
2022
|
Patrick A. Cunningham Chief Compliance Officer |
BUY
Open market or private purchase
|
Direct |
3,100
+2.47%
|
$9,300
$3.1 P/Share
|
|
May 20
2022
|
Edwin C. Reisz Chief Administrative Officer |
BUY
Open market or private purchase
|
Direct |
9,000
+1.0%
|
$18,000
$2.88 P/Share
|
|
May 19
2022
|
Rodney D Windley |
BUY
Open market or private purchase
|
Direct |
36,000
+2.1%
|
$72,000
$2.9 P/Share
|
|
May 19
2022
|
Jeff Shaner Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
9,000
+0.73%
|
$18,000
$2.9 P/Share
|
|
May 19
2022
|
Tony Strange Director |
BUY
Open market or private purchase
|
Direct |
36,000
+2.1%
|
$72,000
$2.9 P/Share
|
|
May 18
2022
|
Steven E Rodgers |
BUY
Open market or private purchase
|
Direct |
6,000
+14.29%
|
$12,000
$2.7 P/Share
|
|
May 17
2022
|
Steven E Rodgers |
BUY
Open market or private purchase
|
Direct |
30,000
+50.0%
|
$60,000
$2.84 P/Share
|
|
May 16
2022
|
David Afshar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
12,036
+4.23%
|
$24,072
$2.86 P/Share
|
|
Feb 14
2022
|
Tony Strange Director |
BUY
Grant, award, or other acquisition
|
Direct |
268,509
+12.3%
|
-
|
|
Feb 14
2022
|
Rodney D Windley |
BUY
Grant, award, or other acquisition
|
Direct |
268,509
+12.31%
|
-
|
|
Feb 14
2022
|
Shannon Drake Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,852
+22.35%
|
-
|
|
Feb 14
2022
|
David Afshar Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
102,130
+28.18%
|
-
|
|
Feb 14
2022
|
Patrick A. Cunningham Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,016
+13.77%
|
-
|
|
Feb 14
2022
|
Beth Rubio Chief Nursing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,819
+15.66%
|
-
|
|
Feb 14
2022
|
Jeff Shaner Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
136,663
+10.13%
|
-
|
|
Feb 14
2022
|
Edwin C. Reisz Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,304
+5.41%
|
-
|
|
Dec 29
2021
|
David Afshar Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
130,000
+45.11%
|
-
|
|
Dec 29
2021
|
Edwin C. Reisz Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+13.1%
|
-
|
|
Dec 29
2021
|
Patrick A. Cunningham Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+42.84%
|
-
|
|
Dec 29
2021
|
Beth Rubio Chief Nursing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+42.84%
|
-
|
|
Dec 29
2021
|
Shannon Drake Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+45.35%
|
-
|
|
Dec 29
2021
|
Jeff Shaner Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
180,000
+14.33%
|
-
|
|
Dec 15
2021
|
Rodney D Windley |
BUY
Open market or private purchase
|
Direct |
15,000
+0.9%
|
$90,000
$6.51 P/Share
|
|
Dec 15
2021
|
Tony Strange Director |
BUY
Open market or private purchase
|
Direct |
15,000
+0.9%
|
$90,000
$6.48 P/Share
|
|
Dec 01
2021
|
David Afshar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,760
+14.44%
|
$28,560
$6.26 P/Share
|
|
Nov 17
2021
|
David Afshar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,850
+14.1%
|
$26,950
$7.73 P/Share
|
|
Aug 13
2021
|
David Afshar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,070
+20.55%
|
$45,630
$9.97 P/Share
|
|
Apr 30
2021
|
David Afshar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,284
+22.77%
|
$47,124
$11.67 P/Share
|
|
Apr 30
2021
|
Jeff Shaner Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+0.11%
|
$11,000
$11.57 P/Share
|